Alzamend Neuro, Inc. ALZN
Set alert
1.48 USD +0.17 +13.14%
As of Nov 3, 3:00 PM ET
1.27 Day range 1.53
0.84 52-week range 2.61
- YTD
- -18.57%
- 1 year
- -41.65%
- Open
- 1.28
- Prev close
- 1.31
- Mkt cap
- 7.15M
- Vol
- 213.07K
- Avg vol
- 79.81K
- EPS
- -2.30
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.27
- High
- 1.53
- Forward P/E
- -0.26
- Beta
- -0.04
- Short ratio
- 1.03
- Inst. own
- 0.94%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 11, 2024
- 50-d avg
- 1.42
- 200-d avg
- 4.08
- 1y target
- 32.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 32.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29 | -0.29 – -0.29 | -3.80 | +92.4% | 0 | 0.0% | 1 |
| Next quarter | -0.45 | -0.45 – -0.45 | -13.35 | +96.6% | 0 | 0.0% | 1 |
| Current year | -1.68 | -1.68 – -1.68 | -14.70 | +88.6% | 0 | 0.0% | 1 |
| Next year | -1.71 | -1.71 – -1.71 | -1.68 | -1.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Nov 11, 2024 | Ascendiant Capital | Maintained | Buy | Buy |